Here, we show that anti–IL-8 antibodies and targeted inhibition of IL-8 signaling by the CXCR-1/-2 blocker reparixin reduced neutrophil activation, degranulation and NET formation caused by COVID-19 plasma. Here, CXCL8 is linked to COVID-19.